beta-ethylstyrene oxide: reagent for measurement of cytosolic epoxide hydrolase; RN given refers to cis isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 125747 |
| MeSH ID | M0088200 |
| Synonym |
|---|
| ccris 6863 |
| trans-2-ethyl-3-phenyloxirane |
| cis-2-ethyl-3-phenyloxirane |
| oxirane, 2-ethyl-3-phenyl-, cis- |
| beta-ethylstyrene oxide |
| (2r,3r)-2-ethyl-3-phenyloxirane |
| 69140-51-8 |
| unii-1hqy57944z |
| 1hqy57944z , |
| cis-.beta.-ethylstyrene oxide |
| 2-ethyl-3-phenyloxirane, cis- |
| oxirane, 2-ethyl-3-phenyl-, (2r,3s)-rel- |
| Q27252432 |
| DTXSID701031859 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 5 (83.33) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.35) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||